Racial Inequities in Receiving Neoadjuvant Treatment in Patients With Pancreatic Cancer Are Associated With Worse Outcomes in Louisiana

Documenti analoghi

• Disparities in Access to Care in the Multimodal Treatment of Primary Nonmetastatic Liver Cancers and Their Impact on Patient Outcomes
  di: McKenzie Hargis, et al.
  Pubblicazione: (2025)
• Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer
  di: Shruti Koti, et al.
  Pubblicazione: (2024)
• Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma
  di: Asmita Chopra, et al.
  Pubblicazione: (2024)
• Correction to “Chemotherapy Switch for Non‐Response or Progression on Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma”
  Pubblicazione: (2026)
• Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases
  di: Omeed Moaven, et al.
  Pubblicazione: (2024)